BA vs LFCR · P/E 89, rev $89.46B vs $207.1M cap
The Boeing Company (BA) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
LFCR does not have a complete income-statement cache yet.
BA currently screens at market cap $177.86B and trailing P/E 89.2. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the BA and LFCR stock pages for the full models.
Not investment advice.